The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs
Samuel T. LoPresti(Carnegie Mellon University), Kathryn A. Whitehead(Carnegie Mellon University), Mariah L. Arral(Carnegie Mellon University), Namit Chaudhary(Scripps Research Institute)
Cited by 270
Related Papers
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
|Nature Reviews Drug Discovery|2021|1.5k
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
|Nature Communications|2014|628
Managing diabetes with nanomedicine: challenges and opportunities
|Nature Reviews Drug Discovery|2014|608
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
|Science Advances|2023|196